ÀÇ·áÁø ã±â
¾Æ·¡ °Ë»öÀ» ÅëÇØ Á¤È®ÇÏ°í ºü¸£°Ô ÀÇ·áÁøÀ» °Ë»öÇÒ ¼ö ÀÖ½À´Ï´Ù.
Áø·á°ú ¾È³»
[¹®ÀÇÀüÈ] 1577-9966
Áø·á°ú¸¦ ¾È³»ÇØ µå¸³´Ï´Ù. Ŭ¸¯ ½Ã ÇØ´ç Áø·á°úÀÇ ÀÚ¼¼ÇÑ »çÇ×À» º¸½Ç ¼ö ÀÖ½À´Ï´Ù.
°£¼¾ÅÍ
-
[SCI]
Is tenofovir disoproxil fumarate an all-powerful weapon in the treatment of chronic hepatitis B?
Kim JH, Lee JS
/ Is tenofovir disoproxil fumarate an all-powerful weapon in the treatment of chronic hepatitis B?
/ 30(1):23-6
/ 201501
-
[SCI]
Genomic predictors for recurrence patterns of hepatocellular carcinoma: model derivation and validation
Kim JH, Sohn BH, Lee HS, Kim SB, Yoo JE, Park YY, Jeong W, Lee SS, Park ES, Kaseb A, Kim BH, Kim WB, Yeon JE, Byun KS, Chu IS, Kim SS, Wang XW, Thorgeirsson SS, Luk JM, Kang KJ, Heo J, Park YN, Lee JS
/ Genomic predictors for recurrence patterns of hepatocellular carcinoma: model derivation and validation
/ 201412
-
[SCI]
Comparison of Lamivudine Plus Adefovir Therapy Versus Entecavir With or Without Adefovir Therapy for Adefovir-resistant Chronic Hepatitis B
Kang SH, Yim HJ, Kim HR, Kang K, Suh SJ, Lee HJ, Yoon EL, Kim JH, Seo YS, Yeon JE, Byun KS
/ Comparison of Lamivudine Plus Adefovir Therapy Versus Entecavir With or Without Adefovir Therapy for Adefovir-resistant Chronic Hepatitis B
/ 48(10):889-95
/ 201412
-
[SCI]
Synergistic effect of simvastatin plus NS398 on inhibition of proliferation and survival in hepatocellular carcinoma cell line
Lee SJ, Hwang JW, Yim H, Yim HJ, Woo SU, Suh SJ, Hyun JJ, Jung SW, Koo JS, Kim JH, Seo YS, Yeon JE, Lee SW, Byun KS, Um SH
/ Synergistic effect of simvastatin plus NS398 on inhibition of proliferation and survival in hepatocellular carcinoma cell line
/ 29(6):1299-307
/ 201406
-
[SCI]
Clinical utility of plasma glypican-3 and osteopontin as biomarkers of hepatocellular carcinoma
Lee HJ, Yeon JE, Suh SJ, Lee SJ, Yoon EL, Kang K, Yoo YJ, Kim JH, Seo YS, Yim HJ, Byun KS
/ Clinical utility of plasma glypican-3 and osteopontin as biomarkers of hepatocellular carcinoma
/ 8(2):177-85
/ 201403